SPHERA FUNDS MANAGEMENT LTD. - Significant Ownership

Signature - Title
Oshrat Levi - Chief Financial Officer
Location
Tel Aviv, Israel
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SPHERA FUNDS MANAGEMENT LTD..

Significant Ownership of SPHERA FUNDS MANAGEMENT LTD.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OTLK Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share 7.49% $3.81M $1.27M 2.57M +50% Sphera Funds Management Ltd. Apr 10, 2025
CMMB Chemomab Therapeutics Ltd. American Depository Shares, each representing twenty (20) ordinary shares, no par value 4.78% $1.28M 900K Sphera Funds Management Ltd. Mar 31, 2025
SKYE Skye Bioscience, Inc. Common Stock, Par Value $0.001 4.77% $3.59M 1.48M Sphera Funds Management Ltd. Mar 31, 2025

Schedules 13D/G Reported by SPHERA FUNDS MANAGEMENT LTD.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.